| Line item | 2025-04-30 FY | 2024-04-30 FY | 2023-04-30 FY | 2023-02-25 FY | 2022-04-30 FY | 2021-04-30 FY |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $1.44M | $1.30M | $1.81M | – | $2.96M | $1.08M |
| R&D | – | – | – | – | – | – |
| SG&A | $1.40M | $1.26M | $1.68M | – | $1.29M | $867.47K |
| Operating Income | -$1.44M | -$1.30M | -$1.81M | – | -$2.96M | -$1.08M |
| Interest Expense | $461.67K | $340.77K | $234.89K | $175.00 | $517.78K | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| Net Income | -$2.30M | -$2.46M | -$1.98M | – | -$228.73K | -$24.53M |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | -0.0002 | -0.0011 | – | – | – | – |
| Shares (diluted) | $10.17B | $7.19B | – | – | – | – |